Abstract:Background Programmed Cell Death 2 Like (PDCD2L) correlates with cell proliferation, apoptosis and mouse embryonic development. However, the role of PDCD2L in human cancers is unclear. Methods Multiple bioinformatic methods, in vitro function experiments and validation were performed to clarify the oncogenic role of PDCD2L in human cancers. Results Our study found that PDCD2L was aberrantly expressed in multiple types of human cancers, and associated with clinical stage and molecular subtype. Furthermore, overexpression of PDCD2L predicted poor overall survival in adrenocortical carcinoma(ACC), kidney chromophobe(KICH), acute myeloid leukemia(LAML), brain lower grade glioma(LGG),liver hepatocellular carcinoma(LIHC), mesothelioma(MESO), uveal melanoma(UVM) and poor diseases free survival in ACC, bladder urothelial carcinoma(BLCA), cervical squamous cell carcinoma and endocervical adenocarcinoma (CESC), kidney renal clear cell carcinoma(KIRC), kidney renal papillary cell carcinoma(KIRP), LGG, LIHC, and UVM. PDCD2L expression was negatively associated with cancer associated fibroblast in breast invasive carcinoma (BRCA), lung squamous cell carcinoma (LUSC), sarcoma (SARC), stomach adenocarcinoma (STAD) and testicular germ cell tumors (TGCT). Mechanically, we found that PDCD2L expression was associated with apoptosis, invasion and cell cycle by investigating single cell sequencing data. For further validation, PDCD2Lwas highly expressed in colorectal cancer (CRC) cell lines and tissue samples compared with the normal colon cell line and non-tumor adjacent colorectal mucosa tissues. PDCD2L knockdown induced the apoptosis and proliferation of CRC cells. Conclusions Our study shows that the oncogenic role of PDCD2L in various cancers and PDCD2L could be served as a biomarker of CRC.

Cellular functions of programmed cell death 5.

PDCD5 (programmed Cell Death 5)

PDCD5 functions as a regulator of p53 dynamics in the DNA damage response

PDCD5 Interacts with P53 and Functions As a Positive Regulator in the P53 Pathway.

Role of Programmed Cell Death 4 in Diseases: a Double-Edged Sword

PDCD5 interacts with p53 and functions as a regulator of p53 dynamics in the DNA damage response

PDCD5 interacts with Tip60 and functions as a cooperator in acetyltransferase activity and DNA damage-induced apoptosis.

Structure-Function Correlation of Human Programmed Cell Death 5 Protein

Cyclin Dependent Kinase 5 and Its Interacting Proteins in Cell Death Induced in Vivo by Cyclophosphamide in Developing Mouse Embryos

Cellular Uptake of Exogenous Human PDCD5 Protein

Multifaceted roles of PDCD6 both within and outside the cell

Expression of Programmed Cell Death 5 Gene Involves in Regulation of Apoptosis in Gastric Tumor Cells

Transgenic human programmed cell death 5 expression in mice suppresses skin cancer development by enhancing apoptosis

Programmed Cell Death 4 is an Inhibitor of Autophagy Via Targeting ATG5 (P1371)

Pdcd5-Regulated Cell Fate Decision after Ultraviolet-Irradiation-Induced Dna Damage

[In Silico Data Mining of the Human Programmed Cell Death 5 (PDCD5) Sequences].

The 5'-upstream region of human programmed cell death 5 gene contains a highly active TATA-less promoter that is up-regulated by etoposide.

Programmed Cell Death Protein 5 (PDCD5) is Phosphorylated by CK2 in Vitro and in 293T Cells.

Nuclear Translocation of PDCD5 (TFAR19): an Early Signal for Apoptosis?

The Clinical Significance of Reduced Programmed Cell Death 5 Expression in Human Gastrointestinal Stromal Tumors.

Pan-cancer Analysis of Oncogenic Role of Programmed Cell Death 2 Like (PDCD2L) and Validation in Colorectal Cancer